February 8, 2017 · STOCK Act disclosure
Representative James B. Renacci (Republican-OH) sold Biogen Inc., a stock transaction, valued at $1,000 - $15,000. The trade took place on February 8, 2017 and was disclosed on February 22, 2017 (owner: Joint). Members of Congress must report such transactions within 45 days under the STOCK Act.